Roles > EC 2.7.1.91 (sphingosine kinase) inhibitor
Page last updated: 2024-08-05 15:45:58
EC 2.7.1.91 (sphingosine kinase) inhibitor
An EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor that interferes with the action of sphinganine kinase (EC 2.7.1.91).
ChEBI ID: 78760
Members (2)
Research
Studies (2,725)
| Timeframe | Studies, Drugs with This Role(%) | All Drugs % |
|---|
| pre-1990 | 854 (31.34) | 18.7374 |
| 1990's | 391 (14.35) | 18.2507 |
| 2000's | 482 (17.69) | 29.6817 |
| 2010's | 646 (23.71) | 24.3611 |
| 2020's | 352 (12.92) | 2.80 |
Study Types
| Publication Type | Studies, Drugs with this Role (%) | All Drugs (%) |
|---|
| Trials | 87 (2.59%) | 5.53% |
| Reviews | 81 (2.41%) | 6.00% |
| Case Studies | 85 (2.53%) | 4.05% |
| Observational | 46 (1.37%) | 0.25% |
| Other | 3,060 (91.10%) | 84.16% |
Protein Targets (3)
Inhibition Measurements